F344.OLETF-(D7Mgh16-D7Mgh20)/Tj |
serum leptin level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood leptin amount |
male |
211 days
| 7 |
|
2.8 |
ng/ml |
0.54 |
1.43 |
enzyme linked immunosorbent assay |
|
0.0 |
oral glucose |
7 |
days |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
|
67484 |
311 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum leptin level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood leptin amount |
male |
211 days
| 11 |
|
6.28 |
ng/ml |
0.51 |
1.69 |
enzyme linked immunosorbent assay |
|
0.0 |
oral glucose |
7 |
days |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
|
67485 |
311 |
DA/K |
serum leptin level |
control condition |
Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. |
blood leptin amount |
not specified |
196 days-224 days |
12 |
|
2.61 |
ng/ml |
0.22 |
0.76 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
96845 |
1123 |
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj |
serum leptin level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood leptin amount |
male |
211 days
| 11 |
|
5.82 |
ng/ml |
0.59 |
1.96 |
enzyme linked immunosorbent assay |
|
0.0 |
oral glucose |
7 |
days |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
|
67486 |
311 |
F344/NSlc |
serum leptin level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood leptin amount |
male |
211 days
| 7 |
|
5.46 |
ng/ml |
1.06 |
2.8 |
enzyme linked immunosorbent assay |
|
0.0 |
oral glucose |
7 |
days |
ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) |
|
67483 |
311 |
BB/OK |
serum leptin level |
control condition |
Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. |
blood leptin amount |
male |
224 days
| 20 |
|
7.7 |
ng/ml |
1.7 |
7.6 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
67940 |
227 |
F344/DuCrlCrlj |
serum leptin level |
fasting (for 16 hours) |
Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6. |
blood leptin amount |
male |
112 days
| 15 |
|
16.32 |
ng/ml |
0.93 |
3.6 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
68971 |
1035 |
BB.SHR-(D4Got41-Tacr1)/K |
serum leptin level |
control condition |
Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. |
blood leptin amount |
male |
224 days
| 20 |
|
15.3 |
ng/ml |
3.5 |
15.65 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
ng/ml |
67941 |
227 |
SS.ZUC-Leprfa-/-/Slc |
serum leptin level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood leptin amount |
male |
126 days
| 7 |
|
53.97 |
ng/ml |
2.34 |
6.19 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
101912 |
2642 |
F344/NRrrc |
serum leptin level |
fasting (for 18 hours) |
Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. |
blood leptin amount |
male |
246 days
| 21 |
|
6.83 |
ng/ml |
0.24 |
1.09 |
enzyme linked immunosorbent assay |
carotid artery |
0 |
|
0 |
|
immunoreactive leptin kit; Morinaga Institute of Biological Science, Yokohama, Japan |
|
65740 |
248 |
OLETF |
serum leptin level |
fasting (for 18 hours) |
Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. |
blood leptin amount |
male |
246 days
| 23 |
|
10.87 |
ng/ml |
0.57 |
2.71 |
enzyme linked immunosorbent assay |
carotid artery |
0 |
|
0 |
|
immunoreactive leptin kit; Morinaga Institute of Biological Science, Yokohama, Japan |
|
65739 |
248 |
BB.WOKW-(D4Got41-Fabp1)/K |
serum leptin level |
control condition |
Kloting N, et al., Obes Res 2005 Mar;13(3):589-95. |
blood leptin amount |
male |
224 days
| 16 |
|
7.7 |
ng/ml |
2.1 |
8.4 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
67942 |
227 |
WOKW |
serum leptin level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
blood leptin amount |
female |
196 days-224 days |
12 |
serial mean |
3.6 |
ng/ml |
|
|
radioimmunoassay |
ophthalmic venous plexus |
0.0 |
|
0 |
|
Roche Cobas Mira Plus (Roche, Switzerland) |
average of measures taken at 196 days, 210 days and 224 days |
67917 |
251 |
DA/K |
serum leptin level |
control condition |
Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. |
blood leptin amount |
female |
196 days-224 days |
12 |
serial mean |
1.8 |
ng/ml |
|
|
radioimmunoassay |
ophthalmic venous plexus |
0.0 |
|
0 |
|
Roche Cobas Mira Plus (Roche, Switzerland) |
average of measures taken at 196 days, 210 days and 224 days |
67918 |
251 |
SS.ZUC-Leprfa+/+/Slc |
serum leptin level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood leptin amount |
male |
126 days
| 6 |
|
1.67 |
ng/ml |
0.37 |
0.91 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
101911 |
2642 |
WOKW/K |
serum leptin level |
control condition |
Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. |
blood leptin amount |
not specified |
196 days-224 days |
12 |
|
7.26 |
ng/ml |
0.85 |
2.94 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
96844 |
1123 |
OLETF/Got |
serum leptin level |
fasting (for 16 hours) |
Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6. |
blood leptin amount |
male |
112 days
| 25 |
|
32.48 |
ng/ml |
1.64 |
8.2 |
enzyme linked immunosorbent assay |
|
0.0 |
|
0 |
|
|
|
68970 |
1035 |